Abstract

We developed a detailed protocol for technology that detects Mycobacterium avium paratuberculosis (MAP) in blood derivatives samples from human by culture and PCR. The technology has potential to be used for screening blood samples from millions of patients with inflammatory and non-inflammatory bowel diseases for MAP.

Document Type

Patent

Patent Number

US 7,488,580

Application Serial Number

11/370,648

Issue Date

2-10-2009

Current Assignee

UCFRF

Assignee at Issuance

UCFRF

College

Burnett School of Biomedical Sciences

Department

Biomolecular Science Center

Allowance Date

11-7-2008

Filing Date

3-8-2006

Assignee at Filing

UCFRF

Filing Type

Nonprovisional Application Record

Donated

no

Share

COinS